Lukas Hartl Selected Research

Lukas Hartl Research Topics

Disease

17	Liver Diseases (Liver Disease) 03/2024 - 01/2021
16	Fibrosis (Cirrhosis) 03/2024 - 01/2021
9	Inflammation (Inflammations) 01/2024 - 01/2021
7	Portal Hypertension 03/2024 - 10/2021
5	Hemorrhage 01/2023 - 01/2021
5	COVID-19 12/2022 - 10/2021
4	Acute-On-Chronic Liver Failure 01/2024 - 01/2022
4	End Stage Liver Disease 04/2023 - 01/2021
3	Chronic Hepatitis D 03/2024 - 01/2022
3	Varicose Veins (Varicose Vein) 03/2024 - 02/2022
3	Ascites 10/2023 - 02/2022
3	Infections 05/2023 - 01/2022
3	Disease Progression 05/2023 - 01/2021
2	Hepatitis 01/2024 - 07/2023
2	Thrombosis (Thrombus) 12/2023 - 01/2022
2	Viremia 09/2023 - 12/2021
2	Cholestasis 12/2022 - 01/2022
2	Aspergillosis 01/2011 - 01/2009
1	Thromboembolism 12/2023
1	Bacterial Infections (Bacterial Infection) 08/2023
1	Non-alcoholic Fatty Liver Disease 07/2023
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 07/2023
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2023
1	Chronic Hepatitis B 01/2023
1	Persistent Infection 01/2023
1	Anemia 12/2022
1	Thrombocytopenia (Thrombopenia) 12/2022
1	Hypersplenism (Anemia, Splenic) 12/2022
1	Leukopenia 12/2022
1	Liver Failure 12/2022
1	Cytopenia 12/2022
1	Hypoalbuminemia 11/2022
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2022
1	Sclerosing Cholangitis 01/2022
1	Thrombophilia 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 12/2021

Drug/Important Bio-Agent (IBA)

8	C-Reactive ProteinIBA 01/2024 - 01/2021
7	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2021
5	4-(3-chlorophenylsulfanyl)piperidineIBA 03/2024 - 02/2022
5	Antiviral Agents (Antivirals)IBA 03/2024 - 01/2022
5	Interleukin-6 (Interleukin 6)IBA 08/2023 - 01/2021
4	RNA (Ribonucleic Acid)IBA 09/2023 - 12/2021
3	von Willebrand FactorIBA 01/2024 - 12/2021
3	ProcalcitoninIBA 05/2023 - 01/2021
2	AntigensIBA 01/2024 - 12/2021
2	CreatinineIBA 10/2023 - 01/2021
2	bulevirtideIBA 08/2023 - 01/2022
2	Propranolol (Inderal)FDA LinkGeneric 01/2023 - 01/2022
2	ReninIBA 12/2021 - 10/2021
2	AldosteroneIBA 12/2021 - 10/2021
2	Antifungal AgentsIBA 11/2010 - 01/2009
1	Thyroid HormonesIBA 01/2024
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2024
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2024
1	Epinephrine (Adrenaline)FDA LinkGeneric 12/2023
1	SodiumIBA 10/2023
1	Hydrocortisone (Cortisol)FDA LinkGeneric 08/2023
1	Bile Acids and Salts (Bile Acids)IBA 08/2023
1	Adrenocorticotropic Hormone (ACTH)FDA Link 08/2023
1	Immunoglobulins (Immunoglobulin)IBA 05/2023
1	Complement System Proteins (Complement)IBA 05/2023
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 05/2023
1	Complement C3cIBA 05/2023
1	Immunoglobulin A (IgA)IBA 05/2023
1	Immunoglobulin G (IgG)IBA 05/2023
1	Immunoglobulin M (IgM)IBA 05/2023
1	AmmoniaIBA 04/2023
1	gadolinium ethoxybenzyl DTPA FDA Link 02/2023
1	Carvedilol (Coreg)FDA LinkGeneric 01/2023
1	Hepatitis B e AntigensIBA 01/2023
1	TransferasesIBA 12/2022
1	Messenger RNA (mRNA)IBA 12/2022
1	BilirubinIBA 12/2022
1	Alkaline PhosphataseIBA 12/2022
1	ochratoxin AIBA 11/2022
1	AlbuminsIBA 11/2022
1	Serum AlbuminIBA 11/2022
1	lipopolysaccharide-binding proteinIBA 01/2022
1	Choline (Choline Chloride)IBA 01/2022
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2022
1	Thioacetamide (Thioacetamid)IBA 01/2022
1	Thrombin FDA Link 01/2022
1	Transaminases (Aminotransferases)IBA 01/2022
1	ThrombomodulinIBA 01/2022
1	PlasminogenIBA 12/2021
1	fibrin fragment D (D-dimer)IBA 12/2021
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2021
1	Prothrombin (Factor II)IBA 12/2021
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 12/2021
1	Natriuretic PeptidesIBA 10/2021
1	Hormones (Hormone)IBA 10/2021
1	AngiotensinsIBA 10/2021

Therapy/Procedure

5	Liver Transplantation 10/2023 - 05/2021
3	Therapeutics 01/2023 - 01/2021
1	Duration of Therapy 08/2023
1	Transjugular Intrahepatic Portasystemic Shunt 12/2022
1	Contraindications 12/2022
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 12/2022
1	Ligation 01/2022
1	Critical Care (Surgical Intensive Care) 10/2021